A 52-year-old woman says to the nurse, "I should have accomplished more in life, what was I thinking?" Which psychosocial crisis is she experiencing?

Choice A reason: Mood stabilizers, like lithium, are used for bipolar disorder to regulate mood swings, not for acute anxiety. They target long-term mood stabilization, not immediate symptom relief, which is critical for post-traumatic anxiety, making this category inappropriate for the patient’s condition.

Choice B reason: Antidepressants, such as SSRIs, treat depression and chronic anxiety over weeks, not acute anxiety. Their delayed onset makes them unsuitable for immediate relief following a traumatic event like a car accident, where rapid symptom management is needed, making this choice incorrect.

Choice C reason: Antipsychotics treat psychosis or severe agitation, not primary anxiety. Their use in anxiety is off-label and typically reserved for cases unresponsive to anxiolytics, with higher side effect risks. This makes them inappropriate for acute anxiety management, rendering this choice incorrect.

Choice D reason: Anxiolytics, like benzodiazepines, provide rapid relief for acute anxiety by enhancing GABA activity, calming the central nervous system. They are the primary choice for short-term management of anxiety post-trauma, aligning with clinical guidelines, making this the correct medication category for patient teaching.

Choice A reason: GABA, an inhibitory neurotransmitter, reduces neuronal activity, not enhances cognitive functions like memory. Memory improvement is associated with cholinergic or glutamatergic systems, not GABA, making this choice incorrect for the expected effect of GABA potentiation.

Choice B reason: Fewer visual hallucinations are associated with antipsychotics affecting dopamine, not GABA. GABA’s inhibitory effects calm the brain but do not directly target psychotic symptoms like hallucinations, making this choice incorrect for the medication’s effect.

Choice C reason: GABA potentiation, as with benzodiazepines, enhances inhibitory effects, reducing neuronal excitability and calming the central nervous system. This directly alleviates anxiety, a primary therapeutic effect, aligning with GABA’s role in anxiety disorders, making this the correct choice.

Choice D reason: Increased alertness is contrary to GABA’s inhibitory effects, which promote sedation. Stimulants, not GABAergic drugs, enhance alertness, making this choice incorrect, as GABA potentiation leads to calming, not stimulating, effects on the brain.